Metlife Inc Forecasted to Post Q1 2018 Earnings of $1.44 Per Share (MET)
Metlife Inc (NYSE:MET) – Research analysts at FBR & Co issued their Q1 2018 earnings estimates for Metlife in a report issued on Thursday. FBR & Co analyst R. Binner expects that the financial services provider will post earnings of $1.44 per share for the quarter. FBR & Co has a “Outperform” rating and a $58.00 price objective on the stock. FBR & Co also issued estimates for Metlife’s Q2 2018 earnings at $1.43 EPS, Q3 2018 earnings at $1.47 EPS, Q4 2018 earnings at $1.42 EPS and FY2018 earnings at $5.75 EPS.
Metlife (NYSE:MET) last posted its quarterly earnings data on Wednesday, May 3rd. The financial services provider reported $1.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.19. Metlife had a net margin of 1.30% and a return on equity of 7.17%. The company had revenue of $16.27 billion during the quarter, compared to analysts’ expectations of $17.02 billion. During the same period in the prior year, the company posted $1.20 earnings per share. Metlife’s revenue for the quarter was down 11.7% compared to the same quarter last year.
A number of other equities research analysts have also commented on MET. Deutsche Bank AG reiterated a “buy” rating and set a $65.00 price target on shares of Metlife in a report on Sunday, February 5th. Royal Bank of Canada reiterated a “buy” rating and set a $61.00 price target on shares of Metlife in a report on Monday, February 6th. Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating in a report on Wednesday, February 15th. Citigroup Inc reiterated a “focus list” rating on shares of Metlife in a report on Tuesday, February 21st. Finally, TheStreet lowered shares of Metlife from a “b-” rating to a “c” rating in a report on Friday, February 24th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $55.94.
Shares of Metlife (NYSE:MET) opened at 51.05 on Friday. Metlife has a 52-week low of $36.17 and a 52-week high of $58.09. The stock’s 50 day moving average is $51.64 and its 200 day moving average is $53.33. The firm’s market capitalization is $54.93 billion.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. First Trust Advisors LP raised its position in shares of Metlife by 15.7% in the third quarter. First Trust Advisors LP now owns 1,107,393 shares of the financial services provider’s stock valued at $49,201,000 after buying an additional 149,958 shares during the period. Quantitative Investment Management LLC increased its stake in Metlife by 189.9% in the third quarter. Quantitative Investment Management LLC now owns 142,900 shares of the financial services provider’s stock worth $6,349,000 after buying an additional 93,600 shares in the last quarter. Aperio Group LLC increased its stake in Metlife by 11.7% in the third quarter. Aperio Group LLC now owns 464,116 shares of the financial services provider’s stock worth $20,621,000 after buying an additional 48,699 shares in the last quarter. Klingenstein Fields & Co. LLC increased its stake in Metlife by 7.1% in the third quarter. Klingenstein Fields & Co. LLC now owns 363,185 shares of the financial services provider’s stock worth $16,136,000 after buying an additional 24,171 shares in the last quarter. Finally, Bank of The Ozarks increased its stake in Metlife by 1.8% in the third quarter. Bank of The Ozarks now owns 19,328 shares of the financial services provider’s stock worth $859,000 after buying an additional 347 shares in the last quarter. Institutional investors and hedge funds own 74.92% of the company’s stock.
In related news, Director James M. Kilts acquired 17,205 shares of the firm’s stock in a transaction on Wednesday, March 22nd. The stock was acquired at an average cost of $51.13 per share, for a total transaction of $879,691.65. Following the acquisition, the director now owns 59,443 shares of the company’s stock, valued at $3,039,320.59. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director James M. Kilts acquired 2,795 shares of the firm’s stock in a transaction on Wednesday, March 1st. The stock was bought at an average price of $54.17 per share, with a total value of $151,405.15. Following the completion of the acquisition, the director now directly owns 41,951 shares in the company, valued at approximately $2,272,485.67. The disclosure for this purchase can be found here. 0.27% of the stock is currently owned by corporate insiders.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 13th. Shareholders of record on Monday, May 8th will be issued a $0.40 dividend. The ex-dividend date is Thursday, May 4th. This represents a $1.60 annualized dividend and a yield of 3.13%. Metlife’s dividend payout ratio (DPR) is presently 262.30%.
Metlife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Stock Ratings for Metlife Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife Inc and related stocks with our FREE daily email newsletter.